Reading Time: < 1 minuteIntroduction Tamoxifen, a widely recognized selective estrogen receptor modulator (SERM), has been extensively used in the management of breast cancer, predominantly in female patients. However, its role and impact on male health, particularly cardiovascular health, have been less explored. This article delves into the findings of a decade-long observational study that scrutinizes the cardiovascular effects of tamoxifen in American males across diverse cohorts. The study's outcomes provide crucial insights into the safety and efficacy of tamoxifen use in this population, guiding clinical practice and future research. Study Design and Methodology The study incorporated a longitudinal design, observing 1,500 American males … Continue reading →